Evidence map›Paper›PMID 37554605›Full record

ArticleCureus2023

Utilization of Telemedicine during COVID-19 in Saudi Arabia: A Multicenter Study.

Abbas Al Mutair, Chandni Saha, Waad Alhuqbani, Mohammed N Alhuqbani, Mohammed N AlQahtani, Ahmad K Abogosh, Abdulaziz M Alsedrah, Alanoud H Alhindi, Reema H Alfehaid, Awad Al-Omari

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Transforming healthcare: Saudi Arabia's vision 2030 healthcare model.Journal of pharmaceutical policy and practice · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Abbas Al MutairResearch Center, Almoosa Health Group, Al Ahsa, SAU.
Chandni SahaResearch Center, Almoosa Health Group, Al Ahsa, SAU.
Waad AlhuqbaniResearch, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU.
Mohammed N AlhuqbaniResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Mohammed N AlQahtaniResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Ahmad K AbogoshResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Abdulaziz M AlsedrahResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Alanoud H AlhindiResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Reema H AlfehaidResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.
Awad Al-OmariResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe outbreak of the novel Coronavirus disease 2019 (COVID-19) has influenced all aspects of life and significantly impacted healthcare services. It has collectively necessitated the use of telemedicine in providing healthcare. Through this study, we aim to report the statistics on telemedicine utilization and satisfaction across the Kingdom of Saudi Arabia during COVID-19.

methodsThis is a cross-sectional study to report the utilization and patient satisfaction with telemedicine services across Saudi Arabia. The data was collected retrospectively from March 2020 to July 2020 on 22,620 patients who used telemedicine services for consultations, medicine refills, and home healthcare visits during COVID-19.

resultsThe patients received a quick response to their calls within a mean (± SD) waiting time of 2.54 (± 6.8) minutes corresponding to a median (IQR) of 0 (0-1) minutes. Home healthcare services were presented within a median (IQR) time of 20.16 (4.64 - 42.28) hours, and patients received medication at home with a median (IQR) time of 18.8 (12.15 - 36.1) hours. Conversations over the phone varied for a median (IQR) time of 5 (3-7) minutes. The highest number of telemedicine calls were for family medicine consultations, i.e., 6729 (29.7%), and the lowest was for infectious diseases 04 (0.1%), followed by cardiology consultations, i.e., 635 (2.8%). A total of 13,154 (58.15) rated their overall satisfaction, of which 11,684 (88.82%) found telemedicine services satisfactory.

conclusionThe utilization of telemedicine across Saudi Arabia results have shown telemedicine to be a satisfactory service for convenient and safe communication between patients and their healthcare providers. It can thus be established as a smart and indissoluble service across the kingdom. However, there is a need to raise awareness of insurance coverage for such services to make them more feasible and accessible to the public.

Indexed as

covid-19home health careretrospective studysaudi arabiatelemedicine

Identifiers

PMID37554605
PMCPMC10404792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.